Based in the United States, Imbria is a startup. Brouky records 1 investor associated with the company.
Imbria is a US-based private company developing drug therapeutics; it is listed in Catalio Capital's private equity portfolio as an unrealized investment.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.